Q13740 (CD166_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 127.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: CD166 antigen Alternative name(s): Activated leukocyte cell adhesion molecule CD_antigen=CD166 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 583 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Cell adhesion molecule that binds to CD6. Involved in neurite extension by neurons via heterophilic and homophilic interactions. May play a role in the binding of T- and B-cells to activated leukocytes, as well as in interactions between cells of the nervous system. |
| Subcellular location | |
| Tissue specificity | Spleen, placenta, liver, and weakly in liver. Expressed by activated T-cells, B-cells, monocytes and thymic epithelial cells. Expressed by neurons in the brain. Restricted expression in tumor cell lines. Preferentially expressed in highly metastasizing melanoma cell lines. Ref.6 |
| Domain | The CD6 binding site is located in the N-terminal Ig-like domain. Ref.7 |
| Sequence similarities | Contains 3 Ig-like C2-type (immunoglobulin-like) domains. Contains 2 Ig-like V-type (immunoglobulin-like) domains. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q13740-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q13740-2) The sequence of this isoform differs from the canonical sequence as follows: 503-516: ISIPEHDEADEISD → N |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 27 | 27 | Potential | ||||||||||||||||||||||||
| Chain | 28 – 583 | 556 | CD166 antigen | PRO_0000014659 | |||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||
| Topological domain | 28 – 527 | 500 | Extracellular Potential | ||||||||||||||||||||||||
| Transmembrane | 528 – 549 | 22 | Helical; Potential | ||||||||||||||||||||||||
| Topological domain | 550 – 583 | 34 | Cytoplasmic Potential | ||||||||||||||||||||||||
| Domain | 28 – 120 | 93 | Ig-like V-type 1 | ||||||||||||||||||||||||
| Domain | 125 – 234 | 110 | Ig-like V-type 2 | ||||||||||||||||||||||||
| Domain | 245 – 328 | 84 | Ig-like C2-type 1 | ||||||||||||||||||||||||
| Domain | 333 – 409 | 77 | Ig-like C2-type 2 | ||||||||||||||||||||||||
| Domain | 416 – 501 | 86 | Ig-like C2-type 3 | ||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||
| Glycosylation | 91 | 1 | N-linked (GlcNAc...) Ref.8 Ref.10 | ||||||||||||||||||||||||
| Glycosylation | 95 | 1 | N-linked (GlcNAc...) Ref.9 Ref.10 | ||||||||||||||||||||||||
| Glycosylation | 167 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||||||||||||||||||
| Glycosylation | 265 | 1 | N-linked (GlcNAc...) Ref.9 | ||||||||||||||||||||||||
| Glycosylation | 306 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 361 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||
| Glycosylation | 457 | 1 | N-linked (GlcNAc...) Ref.10 Ref.11 | ||||||||||||||||||||||||
| Glycosylation | 466 | 1 | N-linked (GlcNAc...) Ref.11 | ||||||||||||||||||||||||
| Glycosylation | 480 | 1 | N-linked (GlcNAc...) Ref.8 Ref.10 | ||||||||||||||||||||||||
| Glycosylation | 499 | 1 | N-linked (GlcNAc...) Ref.8 Ref.9 | ||||||||||||||||||||||||
| Disulfide bond | 43 ↔ 113 | Potential | |||||||||||||||||||||||||
| Disulfide bond | 157 ↔ 220 | Potential | |||||||||||||||||||||||||
| Disulfide bond | 270 ↔ 313 | Potential | |||||||||||||||||||||||||
| Disulfide bond | 354 ↔ 392 | Potential | |||||||||||||||||||||||||
| Disulfide bond | 435 ↔ 485 | Potential | |||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||
| Alternative sequence | 503 – 516 | 14 | ISIPE…DEISD → N in isoform 2. | VSP_021797 | |||||||||||||||||||||||
| Natural variant | 229 | 1 | G → D. Corresponds to variant rs10933819 [ dbSNP | Ensembl ]. | VAR_029514 | |||||||||||||||||||||||
| Natural variant | 258 | 1 | N → S. Corresponds to variant rs1044240 [ dbSNP | Ensembl ]. | VAR_003907 | |||||||||||||||||||||||
| Natural variant | 301 | 1 | T → M. Ref.1 Corresponds to variant rs1044243 [ dbSNP | Ensembl ]. | VAR_003908 | |||||||||||||||||||||||
| Natural variant | 315 | 1 | L → M. Corresponds to variant rs12629872 [ dbSNP | Ensembl ]. | VAR_029515 | |||||||||||||||||||||||
| Natural variant | 352 | 1 | V → M. Corresponds to variant rs2291375 [ dbSNP | Ensembl ]. | VAR_029516 | |||||||||||||||||||||||
| Natural variant | 367 | 1 | M → I. Corresponds to variant rs34926152 [ dbSNP | Ensembl ]. | VAR_049856 | |||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||
| Beta strand | 39 – 44 | 6 | |||||||||||||||||||||||||
| Beta strand | 51 – 59 | 9 | |||||||||||||||||||||||||
| Beta strand | 65 – 71 | 7 | |||||||||||||||||||||||||
| Beta strand | 76 – 80 | 5 | |||||||||||||||||||||||||
| Beta strand | 86 – 90 | 5 | |||||||||||||||||||||||||
| Beta strand | 92 – 102 | 11 | |||||||||||||||||||||||||
| Beta strand | 105 – 107 | 3 | |||||||||||||||||||||||||
| Beta strand | 109 – 117 | 9 | |||||||||||||||||||||||||
| Beta strand | 120 – 123 | 4 | |||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand." Bowen M.A., Patel D.D., Li X., Modrell B., Malacko A.R., Wang W.-C., Marquardt H., Neubauer M., Pesando J.M., Francke U., Haynes B.F., Aruffo A. J. Exp. Med. 181:2213-2220(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT MET-301, PARTIAL PROTEIN SEQUENCE. |
| [2] | "A novel alternatively spliced variant of activated leukocyte cell adhesion molecule (ALCAM/CD166) resulting from a deletion in the extracellular membrane proximal stem." Abe Y., Bui-Thanh N.-A., Smith C.W., Ballantyne C.M., Burns A.R. Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2). |
| [3] | "The DNA sequence, annotation and analysis of human chromosome 3." Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J. Gibbs R.A.Nature 440:1194-1198(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Placenta. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Lung. |
| [6] | "MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule)." Degen W.G., van Kempen L.C., Gijzen E.G., van Groningen J.J., van Kooyk Y., Bloemers H.P.J., Swart G.W. Am. J. Pathol. 152:805-813(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 2-583 (ISOFORM 1), TISSUE SPECIFICITY. |
| [7] | "Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM." Skonier J.E., Bowen M.A., Emswiler J., Aruffo A., Bajorath J. Biochemistry 35:12287-12291(1996) [PubMed] [Europe PMC] [Abstract] Cited for: DOMAIN CD6 BINDING. |
| [8] | "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry." Zhang H., Li X.-J., Martin D.B., Aebersold R. Nat. Biotechnol. 21:660-666(2003) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION AT ASN-91; ASN-167; ASN-480 AND ASN-499. |
| [9] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-95; ASN-265 AND ASN-499, MASS SPECTROMETRY. Tissue: Plasma. |
| [10] | "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry." Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H. J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-91; ASN-95; ASN-457 AND ASN-480, MASS SPECTROMETRY. Tissue: Liver. |
| [11] | "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins." Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M., Schiess R., Aebersold R., Watts J.D. Nat. Biotechnol. 27:378-386(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-457 AND ASN-466, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [12] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [13] | "Molecular model of the N-terminal receptor-binding domain of the human CD6 ligand ALCAM." Bajorath J., Bowen M.A., Aruffo A. Protein Sci. 4:1644-1647(1995) [PubMed] [Europe PMC] [Abstract] Cited for: 3D-STRUCTURE MODELING OF 28-133. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | L38608 mRNA. Translation: AAB59499.1. DQ486139 mRNA. Translation: ABF48405.1. DQ486140 mRNA. Translation: ABF48406.1. AK300362 mRNA. Translation: BAG62102.1. AK316113 mRNA. Translation: BAH14484.1. AC023602 Genomic DNA. No translation available. AC078806 Genomic DNA. No translation available. AC133476 Genomic DNA. No translation available. BC137096 mRNA. Translation: AAI37097.1. BC137097 mRNA. Translation: AAI37098.1. Y10183 mRNA. Translation: CAA71256.1. | ||||||||||||
| IPI | IPI00015102. IPI00807403. IPI00944977. | ||||||||||||
| PIR | I39428. | ||||||||||||
| RefSeq | NP_001230209.1. NM_001243280.1. NP_001618.2. NM_001627.3. | ||||||||||||
| UniGene | Hs.591293. Hs.740441. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q13740. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q13740. 2 interactions. | ||||||||||||
| STRING | 9606.ENSP00000305988. | ||||||||||||
Protein family/group databases | |||||||||||||
| MEROPS | I43.001. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q13740. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 118572629. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q13740. | ||||||||||||
| PRIDE | Q13740. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000306107; ENSP00000305988; ENSG00000170017. ENST00000472644; ENSP00000419236; ENSG00000170017. | ||||||||||||
| GeneID | 214. | ||||||||||||
| KEGG | hsa:214. | ||||||||||||
| UCSC | uc003dvw.2. human. uc003dvy.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 214. | ||||||||||||
| GeneCards | GC03P105085. | ||||||||||||
| HGNC | HGNC:400. ALCAM. | ||||||||||||
| HPA | CAB002148. HPA010926. | ||||||||||||
| MIM | 601662. gene. | ||||||||||||
| neXtProt | NX_Q13740. | ||||||||||||
| PharmGKB | PA24691. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG148902. | ||||||||||||
| HOGENOM | HOG000070101. | ||||||||||||
| HOVERGEN | HBG050847. | ||||||||||||
| InParanoid | Q13740. | ||||||||||||
| KO | K06547. | ||||||||||||
| OMA | GNITWYR. | ||||||||||||
| OrthoDB | EOG4933J2. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_111045. Developmental Biology. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q13740. | ||||||||||||
| Bgee | Q13740. | ||||||||||||
| CleanEx | HS_ALCAM. | ||||||||||||
| Genevestigator | Q13740. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.60.40.10. 5 hits. | ||||||||||||
| InterPro | IPR013162. CD80_C2-set. IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003599. Ig_sub. IPR013106. Ig_V-set. [Graphical view] | ||||||||||||
| Pfam | PF08205. C2-set_2. 1 hit. PF07686. V-set. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00409. IG. 3 hits. [Graphical view] | ||||||||||||
| PROSITE | PS50835. IG_LIKE. 4 hits. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | ALCAM. human. | ||||||||||||
| GenomeRNAi | 214. | ||||||||||||
| NextBio | 866. | ||||||||||||
| PMAP-CutDB | Q13740. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | CD166_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q13740 Secondary accession number(s): B2RNS3 Q1HGM9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
